Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of adjuvant-active nonionic block copolymers.

Todd1, Balusubramanian, Newman

  • 1Vaxcel, Inc., 154 Technology Parkway, Norcross, GA 30092, USA

Advanced Drug Delivery Reviews
|June 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Typhus Fever, Treated by Brandy, &c.

Iowa medical journal·2023
Same author

New Method of Amputating at the Hip-Joint.

Glasgow medical journal·2018
Same author

Intermittent vomiting. [Volvulus of intestine].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Receding chin; difficult breathing.

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Swelling of the neck. [Hodgkin's disease].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Congenital abnormalities. [Bladder duplication].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010

Nonionic block copolymers, used in vaccines, can be customized to enhance specific immune responses. Adjusting polyoxypropylene (POP) core size and polyoxyethylene (POE) content optimizes adjuvant activity and immune cell targeting for tailored vaccine formulations.

Area of Science:

  • Polymer Chemistry
  • Immunology
  • Vaccine Adjuvants

Background:

  • Nonionic block copolymers are synthesized from propylene oxide (PO) and ethylene oxide (EO), forming polyoxyethylene (POE) and polyoxypropylene (POP) blocks.
  • These copolymers exhibit unique physicochemical properties based on PO/EO ratios and block arrangements, with linear POE-POP-POE structures being common in vaccine research.
  • Molecular weight influences formulation: low MW (3-6 kDa) for oil-based emulsions and high MW (>9 kDa) for aqueous formulations.

Purpose of the Study:

  • To investigate how nonionic block copolymer structure influences adjuvant activity and immune response profiles.
  • To explore the potential for 'customizing' vaccine formulations by selecting specific copolymer structures.

Main Methods:

  • Evaluation of linear POE-POP-POE nonionic block copolymers.

Related Experiment Videos

  • Analysis of adjuvant activity in relation to polyoxypropylene (POP) core block size.
  • Assessment of adjuvant activity and immune response type based on polyoxyethylene (POE) content.

    • Main Results:

    • Adjuvant activity increases with POP core size, peaking at 12-15 kDa.
    • Optimal adjuvant activity is observed with 5-10% POE content.
    • Copolymers with 10% POE favor Type 2 T-helper cell responses (antibody/mucosal), while <10% POE augments both Type 1 and Type 2 responses (broader antibody/cellular immunity).

    Conclusions:

    • Nonionic block copolymer structure, particularly POP core size and POE content, significantly impacts adjuvant efficacy and immune response modulation.
    • These tunable properties allow for the rational design of nonionic block copolymers as adjuvants to elicit specific immune responses for customized vaccine development.